Jilin Cayman Pharmaceutical

Jilin Cayman Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates modern, GMP-certified manufacturing facilities in Jilin Province, focusing on therapeutic areas such as cardiovascular health, anti-infectives, and analgesics. Its product portfolio includes widely used small molecule drugs like statins and ACE inhibitors, serving both the domestic Chinese market and international clients. Jilin Cayman is recognized for its integrated approach to chemical synthesis and pharmaceutical formulation, ensuring high quality and regulatory compliance.